Sort
23,748 grants matching “melanoma”
Ligand Recognition by Phospholipid Growth Factor Receptors
$285,624Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2009 · CA
Transduction of Hematopoietic Stem Cells for Enhanced Immunotherapy of Melanoma
$285,613Donald B Kohn · California Institute Of Technology · P01 · FY2012 · CA
B7-DC Cross-linking antibody immunotherapy
$285,593Svetomir Nenad Markovic · Mayo Clinic Rochester · R21 · FY2008 · CA
Mimimal-Perturbation Dynamic Control of the Melanoma Gene Regulatory Network
$285,550Dan Schonfeld · University Of Illinois At Chicago · R01 · FY2012 · GM
Obesity Affects Immunity to Kidney Cancer
$285,544Lyse A Norian · University Of Alabama At Birmingham · R01 · FY2017 · CA
Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC
$285,493James P Allison · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Contrast Ultrasound Detection of Sentinel Lymph Nodes in Breast Cancer Patients
$285,480Flemming Forsberg · Thomas Jefferson University · R01 · FY2016 · CA
Contrast Ultrasound Detection of Sentinel Lymph Nodes in Breast Cancer Patients
$285,480Flemming Forsberg · Thomas Jefferson University · R01 · FY2017 · CA
Light-responsive ruthenium compounds for applications in disease
$285,477Edith C Glazer · University Of Kentucky · R01 · FY2017 · GM
Light-responsive ruthenium compounds for applications in disease
$285,477Edith C Glazer · University Of Kentucky · R01 · FY2015 · GM
Light-responsive ruthenium compounds for applications in disease
$285,477Edith C Glazer · University Of Kentucky · R01 · FY2018 · GM
Ligand Recognition by Phospholipid Growth Factor Receptors
$285,473Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2010 · CA
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
$285,463Rajesh Agarwal · University Of Colorado Denver · R01 · FY2013 · CA
CLINICAL DEVELOPMENT OF HU14.18 IL2 TARGETED THERAPY
$285,407University Of Wisconsin Madison · R01 · FY2000 · CA
Regulation of apoptosis in melanocytic cells
$285,386Douglas Grossman · University Of Utah · R01 · FY2008 · AR
POLYAMINE ANALOG AND INHIBITOR REGULATION OF CELL CYCLE
$285,371Roswell Park Cancer Institute Corp · R01 · FY2000 · CA
Project 1: Tropical Plants Biological Testing
$285,325Alan Douglas Kinghorn · Ohio State University · P01 · FY2022 · CA
Core 2: Computational and Data Integration
$285,307Kelly Valentine Ruggles · New York University School Of Medicine · U54 · FY2023 · CA
IL-1 HOMOLOGUES PROMOTE THE ACUTE INFLAMMATORY RESPONSE
$285,303Michael T Lotze · University Of Pittsburgh At Pittsburgh · P01 · FY2006 · CA
B7-DC Cross-linking antibody immunotherapy
$285,291Svetomir Nenad Markovic · Mayo Clinic Rochester · R21 · FY2007 · CA
B LYMPHOCYTE INDUCED MATURATION PROTEIN
$285,253Columbia University Health Sciences · R01 · FY2000 · AI
Control of cancer and metastasis by endothelial-derived epoxyeicosatrienoic acids
$285,244Dipak Panigrahy · Boston Children'S Hospital · R01 · FY2010 · CA
Project 1: Genotoxic & Cell Signaling Pathways of As in Mammalian Cells
$285,218Tom K Hei · Columbia University Health Sciences · P42 · FY2010 · ES
Elucidating Mechanisms of Resistance using Genetically Engineered Mouse Models
$285,140Lynda Chin · Massachusetts General Hospital · P01 · FY2014 · CA
Immunization Against Melanoma Differentiation Antigens
$285,132Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA